NervGen Shares Rise After Receiving FDA Breakthrough Therapy Designation for NVG-291 to Treat Spinal Cord Injury
02:44 PM EST, 11/12/2026 (MT Newswires) -- NervGen (NGEN) shares rose over 6% on Thursday after it s
Related stories
Family Dollar to Pay $63 Million to Settle Upcharging Claims
Family Dollar agreed to pay $63 million to settle government allegations that it charged customers more at checkout than the prices displayed on shelves and tags.
M impact | REGULATION | Nov 12, 2026, 08:06 PM UTC
US Says It Returned More Than $12 Billion in Oil Proceeds to Venezuela
The Trump administration says it has returned more than $12 billion in oil proceeds to Venezuela.
M impact | REGULATION | Nov 12, 2026, 06:39 PM UTC
Health Canada Warns After Bacteria Found in Unauthorized Peptides
Health Canada warned after bacteria were found in unauthorized peptides.
L impact | REGULATION | Nov 12, 2026, 06:20 PM UTC
White House Discusses Howard Lutnick’s Future as Commerce Secretary
People familiar say the White House is discussing Howard Lutnick’s future as Commerce Secretary.
L impact | REGULATION | Nov 12, 2026, 06:13 PM UTC
White House Set to Extend Jones Act Shipping Waiver, Sources Say
L impact | REGULATION | Nov 12, 2026, 05:48 PM UTC
Family Dollar Reaches $63 Million Settlement With FTC, 17 States
Family Dollar reached a $63 million settlement with the US Federal Trade Commission and 17 states over allegations that it overcharged shoppers, including by charging more at check
M impact | REGULATION | Nov 12, 2026, 05:45 PM UTC